7497755

Source:http://linkedlifedata.com/resource/pubmed/id/7497755

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0018787, umls-concept:C0019010, umls-concept:C0021467, umls-concept:C0021469, umls-concept:C0031640, umls-concept:C0086418, umls-concept:C0205195, umls-concept:C0205464, umls-concept:C1280500, umls-concept:C1948023
pubmed:issue	6
pubmed:dateCreated	1996-1-17
pubmed:abstractText	We measured the individual and combined effects of the beta-agonist dobutamine and the phosphodiesterase inhibitor enoximone both in vitro and in vivo in the failing human heart.
pubmed:grant	http://linkedlifedata.com/resource/pubmed/grant/3M01 RR00064-25S1
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0231335
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Adrenergic beta-Agonists, http://linkedlifedata.com/resource/pubmed/chemical/Cyclic AMP, http://linkedlifedata.com/resource/pubmed/chemical/Dobutamine, http://linkedlifedata.com/resource/pubmed/chemical/Enoximone, http://linkedlifedata.com/resource/pubmed/chemical/Nitroprusside, http://linkedlifedata.com/resource/pubmed/chemical/Phosphodiesterase Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Vasodilator Agents
pubmed:status	MEDLINE
pubmed:month	Dec
pubmed:issn	0012-3692
pubmed:author	pubmed-author:BristowM RMR, pubmed-author:GilbertE MEM, pubmed-author:HershbergerR ERE, pubmed-author:MovsesianM AMA, pubmed-author:WiechmannR JRJ
pubmed:issnType	Print
pubmed:volume	108
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1524-32
pubmed:dateRevised	2007-11-15
pubmed:meshHeading	pubmed-meshheading:7497755-Adolescent, pubmed-meshheading:7497755-Adrenergic beta-Agonists, pubmed-meshheading:7497755-Adult, pubmed-meshheading:7497755-Aged, pubmed-meshheading:7497755-Aged, 80 and over, pubmed-meshheading:7497755-Cardiac Output, Low, pubmed-meshheading:7497755-Cyclic AMP, pubmed-meshheading:7497755-Dobutamine, pubmed-meshheading:7497755-Dose-Response Relationship, Drug, pubmed-meshheading:7497755-Drug Therapy, Combination, pubmed-meshheading:7497755-Enoximone, pubmed-meshheading:7497755-Female, pubmed-meshheading:7497755-Hemodynamics, pubmed-meshheading:7497755-Humans, pubmed-meshheading:7497755-Male, pubmed-meshheading:7497755-Middle Aged, pubmed-meshheading:7497755-Myocardial Contraction, pubmed-meshheading:7497755-Myocardium, pubmed-meshheading:7497755-Nitroprusside, pubmed-meshheading:7497755-Phosphodiesterase Inhibitors, pubmed-meshheading:7497755-Prospective Studies, pubmed-meshheading:7497755-Vasodilator Agents, pubmed-meshheading:7497755-Ventricular Function
pubmed:year	1995
pubmed:articleTitle	Pharmacologic and hemodynamic effects of combined beta-agonist stimulation and phosphodiesterase inhibition in the failing human heart.
pubmed:affiliation	University of Utah Heart Failure Treatment Program, Salt Lake City, USA.
pubmed:publicationType	Journal Article, In Vitro, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't